AI-driven and Phenotype-based Drug Design
Jun 7, 2026
·
1 min read
My earlier work focused on molecular generation, allosteric regulation, CRISPR-Cas9 conformational dynamics, and computational-experimental workflows for drug discovery. I am especially interested in phenotype-based drug design, where cellular response, molecular mechanism, and perturbation design are linked into one therapeutic discovery loop.
